Piramal Enterprises has received approval to raise up to Rs 3000 crore through public issuance of Secured, Rated, Listed, Redeemable, Non-Convertible Debentures (NCDs) of face value of Rs 1,000 each in one or more tranches, subject to regulatory and statutory approvals, as applicable. The Administrative Committee of the Board of Directors (Committee) at their meeting held on August 22, 2023 approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
